7-Bromo-5-chloro-8-hydroxyquinoline
CAS : 7640-33-7
Ref. 3D-FB62195
| 1g | Arrêté | ||
| 2g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 25g | Arrêté |
Informations sur le produit
Nom :
7-Bromo-5-chloro-8-hydroxyquinoline
Synonymes :
- 5-Chlor-7-brom-8-hydroxychinolin
- 5-Chlor-7-brom-8-hydroxychinolin [German]
- 5-Chloro-7-bromo-8-hydroxyquinoline
- 5-Chloro-7-bromo-8-quinolinol
- 7-Bromo-5-chloro-8-quinolinol
- 8-Quinolinol, 7-bromo-5-chloro-
- Brn 0153623
Description :
7-Bromo-5-chloro-8-hydroxyquinoline (BCHQ) is a drug that has been shown to have anticancer activity in vitro. It has been found to bind to the matrix of the cancer cells and inhibit their growth. It also binds to plasma proteins, which may reduce its bioavailability. BCHQ has demonstrated chemotherapeutic activity against tuberculosis in vivo and in vitro, but it has not yet been clinically developed for this indication. When given orally, 7-Bromo-5-chloro-8-hydroxyquinoline inhibits protein synthesis in Sprague Dawley rats by a mechanism that requires methionine aminopeptidase activity. It can be detected in urine samples using LC/MS/MS methods.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
